Cohizon Life Sciences Limited, a active public limited company, was established on 17 September 1983 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U51900MH1983PLC030874. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹11.02 Cr and a paid-up capital of ₹3.18 Cr.
Formerly known as Sajjan Impex Pvt Limited, Sajjan Impex Limited. It upholds a compliant status. Employing 960 professional, Its leadership includes Rajesh Kumar Srivastava (Ceo), Steven Andre J Buyse (Director), Anant Jain (Director). Past directors included Rajesh Kumar Srivastava, Raghunathan Ananthanarayanan, Pawan Kumar Agarwal. It holds ₹356.00 Cr open charges and ₹151.85 Cr settled loans. Its latest AGM occurred on 20 August 2025, with the balance sheet filed on 31 March 2025. It is based at Urmi Estate, Tower A, 14Th Floor, 95, Ganpatrao Kadam Marg, Lower Parel (W, ), Mumbai, Maharashtra, 400013.
U51900MH1983PLC030874
030874
17 September 1983
₹11.02 Cr
₹3.18 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cohizon Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kumar Srivastava | Ceo | 17 Apr 2024 | Current |
| Steven Andre J Buyse | Director | 25 May 2022 | Current |
| Anant Jain | Director | 25 May 2022 | Current |
| Rajan Hamir Gajaria | Director | 22 Feb 2024 | Current |
| Anurag Surana | Director | 25 Nov 2023 | Current |
| Dirk Backhaus | Director | 26 Jun 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Aug 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 May 2022 | Past |
| Pramod Abcsdd | Cfo | 10 Jul 2024 | Past |
| Pramod Abcsdd | Director | 25 May 2022 | Past |
| Pramod Abcsdd | Director | 19 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 10 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cohizon Life Sciences Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 27.77% decrease. The company also saw a substantial fall in profitability, with a 61.54% decrease in profit. The company's net worth moved up by a moderate rise of 0.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Cohizon Life Sciences had a promoter holding of 88.81% and a public holding of 11.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,560,000,000.00
₹1,518,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2025 | Axis Bank Limited | ₹50.00 Cr | Open |
| 13 Nov 2024 | Others | ₹50.00 Cr | Open |
| 14 Jun 2023 | Axis Bank Limited | ₹150.00 Cr | Open |
| 06 Dec 2022 | Others | ₹1.00 Cr | Open |
| 04 Jan 2020 | Others | ₹30.00 Cr | Open |
Explore comprehensive loan charge details -
Cohizon Life Sciences has a workforce of 960 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cohizon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cohizon Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cohizon Life Sciences Limited last Annual general meeting of members was held on 20 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101113011 was registered on 09 Jun 2025. was documented.
Progress on Chandra Bose Bhardwaj was appointed as a Whole-time director was appointed as a Whole-time director on 27 May 2025 & has been associated with this company since 6 months 30 days . was documented.
Progress on A charge registered on 15 Oct 2009 via Charge ID 10182498 with Standard Chartered Bank was fully satisfied on 03 Apr 2025. was documented.
Progress on Cohizon Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Neha Sureka was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2025 & has been associated with this company since 9 months 28 days . was recorded as a recent event.
The CIN of Cohizon Life Sciences Limited is U51900MH1983PLC030874.
Cohizon Life Sciences Limited is headquartered at Urmi Estate, Tower A, 14Th Floor, 95, Ganpatrao Kadam Marg, Lower Parel (W, ), Mumbai, Maharashtra, 400013.
Cohizon Life Sciences Limited was incorporated on 17 September 1983.
The current directors of Cohizon Life Sciences Limited are
The primary industry of Cohizon Life Sciences Limited is Manufacturing.
Cohizon Life Sciences Limited is unlisted.
The authorized capital of Cohizon Life Sciences Limited is ₹11.02 Cr, and the paid-up capital is ₹3.18 Cr.
The compliance status of Cohizon Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX